This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Stantec (STN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Stantec (STN) delivered earnings and revenue surprises of 2.13% and 1.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Top Stocks to Watch From the Advertising & Marketing Industry
by Zacks Equity Research
The Zacks Advertising and Marketing industry's prospects look good on healthy manufacturing and service activities. OMC, HHS and WPP are likely to be industry frontrunners on digital marketing surge and client-centric strategies.
Is Harte Hanks (HHS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Omnicom (OMC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Omnicom (OMC) delivered earnings and revenue surprises of 8.59% and 5.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Harte-Hanks (HHS) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Harte-Hanks (HHS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
3 Advertising Stocks Poised to Escape COVID-19-Led Industry Weakness
by Zacks Equity Research
While the Omicron surge leads to tightening restrictions, the Zacks Advertising and Marketing Industry's prospects look good on healthy manufacturing and service activities. OMC, HHS and WPP will likely be the industry frontrunners on digital marketing surge and client-centric strategies.
Here's Why "Trend" Investors Would Love Betting on Harte-Hanks (HHS)
by Zacks Equity Research
Harte-Hanks (HHS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Recent Price Trend in Harte-Hanks (HHS) is Your Friend, Here's Why
by Zacks Equity Research
Harte-Hanks (HHS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Harte-Hanks (HHS) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
by Zacks Equity Research
Harte-Hanks (HHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertising & Marketing Outlook Dull Amid Coronavirus Mayhem
by Shuvra Shankar Dey
Significant rise in digital media consumption should be able to somewhat offset the coronavirus crisis' unfavorable impact on the industry.
All You Need to Know About Harte-Hanks (HHS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Harte-Hanks (HHS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
National CineMedia (NCMI) Jumps: Stock Rises 10.6%
by Zacks Equity Research
National CineMedia (NCMI) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
4 Advertising & Marketing Stocks to Gain Amid Coronavirus Scare
by Zacks Equity Research
With strict lockdowns across the globe in the wake of coronavirus outbreak, people are spending more time indoor on various media platforms and streaming video services.
Harte-Hanks (HHS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of -92.21% and 2.87%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Harte-Hanks (HHS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Harte-Hanks (HHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harte-Hanks (HHS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of 169.39% and 2.50%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Harte-Hanks (HHS) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of -31.17% and -5.38%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Advertising and Marketing Outlook: Dismal Show Continues
by Zacks Equity Research
With the FBI examining buying practices in media, the industry continuous to grapple with tremendous pressure.
Harte-Hanks (HHS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Harte-Hanks (HHS) delivered earnings and revenue surprises of -74.60% and -12.41%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Weight Watchers, Johnson Outdoors, ChemoCentryx, Harte-Hanks and IEC
by Zacks Equity Research
Zacks.com featured highlights include: Weight Watchers, Johnson Outdoors, ChemoCentryx, Harte-Hanks and IEC
7 Stocks With Recent Price Strength to Enhance Your Returns
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Why MDC Partners (MDCA) Could Be Positioned for a Slump
by Zacks Equity Research
MDC Partners (MDCA) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
Harte Hanks (HHS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Harte Hanks, Inc. (HHS).
Harte Hanks Amends Credit Facility to Improve Liquidity
by Zacks Equity Research
The modified credit agreement is likely to provide the means to undertake strategic investments to spur long-term growth of Harte Hanks, Inc. (HHS).
Harte Hanks Partners with Usermind to Enhance Portfolio
by Zacks Equity Research
Harte Hanks, Inc. (HHS), recently announced its collaboration with Usermind's Customer Engagement Hub, to provide customers consulting and data management solutions.